Crosstalk between immune checkpoint and DNA damage response inhibitors for radiosensitization of tumors

被引：0
|
作者：
Sandra Classen
Cordula Petersen
Kerstin Borgmann
机构：
[1] University Medical Center Hamburg-Eppendorf,Laboratory of Radiobiology and Radiation Oncology, Department of Radiotherapy and Radiation Oncology, Center of Oncology
[2] University Medical Center Hamburg-Eppendorf,Department of Radiotherapy and Radiation Oncology
来源：
Strahlentherapie und Onkologie | 2023年 / 199卷
关键词：
DNA repair; DNA damage response; cGAS/STING activation; Cytosolic dsDNA; PARP inhibition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1152 / 1163
页数：11
相关论文
共 50 条
  • [41] Advances in the application of immune checkpoint inhibitors in gynecological tumors
    Zou, YingGang
    Xu, Ying
    Chen, XiaoChen
    Zheng, Lianwen
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 117
  • [42] Are DNA Repair Gene Alterations Associated With the Response to Platinum-Based Regimen and Immune Checkpoint Inhibitors in Patients With Solid Tumors?
    Chabot, Clement
    Italiano, Antoine
    Crombe, Amandine
    Soubeyran, Isabelle
    Laizet, Yech'an
    Khalifa, Emmanuel
    Cousin, Sophie
    [J]. ONCOLOGIST, 2024, : 452 - 455
  • [43] Diverse immune response of DNA damage repair-deficient tumors
    Qing, Tao
    Jun, Tomi
    Lindblad, Katherine E.
    Lujambio, Amaia
    Marczyk, Michal
    Pusztai, Lajos
    Huang, Kuan-lin
    [J]. CELL REPORTS MEDICINE, 2021, 2 (05)
  • [44] Inhibition of the DNA damage response to activate immune responses toward tumors
    Sharma, Sheetal
    Srivastava, Mrinal
    [J]. FEBS JOURNAL, 2021, 288 (15) : 4503 - 4506
  • [45] Predicting response of tumors to immune checkpoint therapy
    Brownell, I.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (12) : 2499 - 2499
  • [46] The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer
    Xie, Deqian
    Jiang, Bowen
    Wang, Shijin
    Wang, Qifei
    Wu, Guangzhen
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [47] Diabetes and Immune Checkpoint Inhibitors-Response
    Cortellini, Alessio
    D'Alessio, Antonio
    Pinato, David J.
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (19) : 4017 - 4018
  • [48] Predictive biomarkers of response to immune checkpoint inhibitors
    Sacramento Diaz-Carrasco, Maria
    Gonzalez-Haba, Eva
    Ines Garcia-Soler, Juana
    Espuny-Miro, Alberto
    [J]. FARMACIA HOSPITALARIA, 2020, 44 (04) : 141 - 148
  • [49] Predictive biomarkers of response to immune checkpoint inhibitors
    Frelau, Alexandra
    Pracht, Marc
    Le Sourd, Samuel
    Lespagnol, Alexandra
    Corre, Romain
    Menard, Cedric
    Tarte, Karin
    Mosser, Jean
    Edeline, Julien
    [J]. BULLETIN DU CANCER, 2018, 105 : S80 - S91
  • [50] Understanding Suboptimal Response to Immune Checkpoint Inhibitors
    Zhu, Mojun
    Zhang, Henan
    Pedersen, Katrina S.
    Foster, Nathan R.
    Jaszewski, Brandy L.
    Liu, Xin
    Hirdler, Jacob B.
    An, Zesheng
    Bekaii-Saab, Tanios S.
    Halfdanarson, Thorvardur R.
    Boland, Patrick M.
    Yan, Yiyi
    Hubbard, Joleen H.
    Ma, Wen Wee
    Yoon, Harry H.
    Revzin, Alexander
    Fernandez-Zapico, Martin E.
    Overman, Michael J.
    McWilliams, Robert R.
    Dong, Haidong
    [J]. ADVANCED BIOLOGY, 2023, 7 (04):
12345